Literature DB >> 6547443

In the search for new anticancer drugs. VII. Platinum complexes of diaziridines and azetidine.

G Sosnovsky, J Lukszo.   

Abstract

Three new diaziridine platinum(II) complexes (4a)-(4c), and a new azetidine platinum(II) complex (3b) were synthesized and tested against the lymphocytic leukemia P388 in mice. (formula; see text) Moderate to good activity was found for all compounds as evidenced by a T/C value of 162 at a dose of 32 mg/kg for (3b), 190 at a dose of 32 mg/kg for (4a), 139 at a dose of 4 mg/kg for (4b), and 142 at a dose of 20 mg/kg for (4c).

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6547443     DOI: 10.1007/bf01032610

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  5 in total

1.  New platinum complexes with anti-tumour activity.

Authors:  T A Connors; M Jones; W C Ross; P D Braddock; A R Khokhar; M L Tobe
Journal:  Chem Biol Interact       Date:  1972-11       Impact factor: 5.192

2.  Platinum compounds: a new class of potent antitumour agents.

Authors:  B Rosenberg; L VanCamp; J E Trosko; V H Mansour
Journal:  Nature       Date:  1969-04-26       Impact factor: 49.962

Review 3.  Platinum compounds in cancer chemotherapy.

Authors:  G Pouskouleli; P Kourounakis
Journal:  Biochem Exp Biol       Date:  1980

4.  Antileukemia (L1210) activity and toxicity of cis-dichlorodiammineplatinum(II) analogs.

Authors:  A W Prestayko; W T Bradner; J B Huftalen; W C Rose; J E Schurig; M J Cleare; P C Hydes; S T Crooke
Journal:  Cancer Treat Rep       Date:  1979 Sep-Oct

5.  Nephrotoxicity of cis-platinum (II) dichlorodiammine.

Authors:  J J Stark; S B Howel
Journal:  Clin Pharmacol Ther       Date:  1978-04       Impact factor: 6.875

  5 in total
  1 in total

Review 1.  Advances in platinum cancer chemotherapy. Advances in the design of cisplatin analogues.

Authors:  P C Hydes; M J Russell
Journal:  Cancer Metastasis Rev       Date:  1988-04       Impact factor: 9.264

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.